Product Center
Obtained recognition as one of the first offshore innovation centers for enterprises in Taizhou
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-08-14
- Views:
(Summary description) Recently, the Science and Technology Bureau of Taizhou City announced the first batch of offshore innovation centers for enterprises, and Ab&B Bio-Tech Co.,Ltd(Ab&B Bio) wholly-owned subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) Successfully obtained recognition.
Obtained recognition as one of the first offshore innovation centers for enterprises in Taizhou
(Summary description) Recently, the Science and Technology Bureau of Taizhou City announced the first batch of offshore innovation centers for enterprises, and Ab&B Bio-Tech Co.,Ltd(Ab&B Bio) wholly-owned subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) Successfully obtained recognition.
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-08-14 18:02
- Views:
Recently, the Science and Technology Bureau of Taizhou City announced the first batch of offshore innovation centers for enterprises, and Ab&B Bio-Tech Co.,Ltd(Ab&B Bio)wholly-owned subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) Successfully obtained recognition.
Since its establishment, Yither Bio has jointly established a collaborative innovation model of "offshore research and development incubation, local transformation and application" with Ab&B Bio, leveraging advanced regional innovative resources to carry out key core technology research and development. As of now, two clinical approvals for Class I new drugs have been successfully jointly applied for and approved.
Next, the company will also actively promote the two-way linkage between local innovation and offshore innovation, strengthen the exchange, interaction and circulation of talents, cultivate a batch of scientific and technological innovation achievements, and continue to complete the implementation and application of innovation achievements, so as to help the high-quality development of the city's biomedical industry!
Relevant information
-
Ab&B Bio and Yither Bio have both obtained qualification certification!
Recently, Ab&B Bio-Tech Co.,Ltd(Ab&B Bio) and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) have been recognized as Jiangsu Province's specialized and innovative small and medium-sized enterprises and national high-tech enterprises, respectively. - The kickoff meeting for clinical research on the immunogenicity and safety of quadrivalent influenza virus subunit vaccine for children with nephrotic syndrome was successfully held 12-25
- Influenza virus subunit vaccine (adjuvant) IND application approved 10-30
- The application for the marketing of trivalent influenza virus subunit vaccine has been accepted! 10-08
- Breaking through bottleneck technology, significant progress has been made in the research and development of new adjuvants 08-26
Have a project?Get a touch!
Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio
Contact
E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us